ER Wildtype
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| PhII Randomized CAPecitabine + ELAcestrant vs. Capecitabine Alone in ER+ Breast Cancer (CAPELA) (NCT07222215) | Kristina A. Fanucci | 2026-01-16 |
Track ER Wildtype automatically
Every clearance here is in the API, with alerts when new ones post.